A revolutionary medication , retatrutide, is generating considerable excitement within the Oz weight control community. Developed by Eli Lilly , this dual GIP and GLP-1 receptor appears to provide more substantial results than current therapies. Preliminary medical trials have shown remarkable reductions in body mass, suggesting a for a new method